Has Richard Gralla received payments from drug or device companies?

Yes. Drug and device makers reported $159,229 in general payments to Richard Gralla across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Gralla did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Gralla come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Gralla

Hematology & Oncology · New Hyde Park, NYNPI 1710167002

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Helsinn Healthcare SA accounts for 63.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $85,183 and has fallen 99.9% since, to $43 in 2025. Among hematology & oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$159,229in general payments, 2019–2025

Across 76 payments — averaging $2095.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Helsinn Healthcare SA$100K
Purdue Pharma$22K
Vifor (international) Ltd.$17K
Eli Lilly$12K
Bayer$6K
Heron Therapeutics, Inc.$2K
plus $728 from 1 others

$163,439in research payments, 2019–2025

Across 25 payments — averaging $6537.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$163K

What the payments were for

Consulting fees$70,33844%
Speaking & faculty fees$29,32218%
Travel & lodging$58,22337%
Food & beverage$1,3031%
Education$430%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Helsinn Healthcare SA	36	$100,398
Purdue Pharma	1	$21,640
Vifor (international) Ltd.	3	$16,501
Eli Lilly	30	$11,766
Bayer	2	$6,073
Heron Therapeutics, Inc.	2	$2,123
AstraZeneca	2	$728

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AKYNZEO$87,933
CINVANTI$2,123
SUSTOL$2,123
IMFINZI$685

How this compares

$159,229 in reported general payments places this provider in the 95th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Erlotinib Hcl	11	$53,709

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in New Hyde Park

Tarun WasilNew Hyde Park$147K
Michael SchusterNew York$1.6M
Charles SawyersNew York$1.6M
Manuel Hidalgo-MedinaNew York$1.4M
Francis ArenaLake Success$1M
Sanjeev JainEast Patchogue$971K
Ross LevineNew York$968K
Perry CookBrooklyn$803K
Mihir RavalAlbany$767K
Joshua SabariNew York$761K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →